July 31, 2013
Company Quickly Responds to Request for Compassionate Use of Alternating Electric Field Therapy St. Helier, Jersey – July 31, 2013 – Novocure today announced that Dr. Tatsunori Okamaura, MD, Ph.D., … Continued
July 22, 2013
FOR IMMEDIATE RELEASE SynapDx Corporation Secures $15.4M in Funding Led by Google Ventures Investment Propels Development of SynapDx’s Innovative Blood Test for the Early Diagnosis of Autism Lexington, MA – … Continued
July 01, 2013
FOR IMMEDIATE RELEASE Largest Prospective Multi-site Autism Clinical Study Offers Promise of Earlier Diagnosis for Improved Outcomes SynapDx Corporation Evaluates Blood-based Autism Test Designed to Enable Clinicians and parents to … Continued